Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Comparison of continuous 24-h and 14-day monitoring for detection of otherwise unknown atrial fibrillation: a registry to identify Japanese concealed atrial fibrillation (REAL-AF)-based study.

Nagashima K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Kojima T, Ando H, Nomoto K, Arima K, Hirayama A; REAL AF StudyInvestigators.

Heart Vessels. 2019 Nov 6. doi: 10.1007/s00380-019-01535-6. [Epub ahead of print]

PMID:
31696252
2.

Translin restricts the growth of pubertal mammary epithelial cells estrogen-independently in mice.

Matsubara L, Fukuoka T, Sudo K, Fukunaga T, Imanishi A, Kuronuma K, Matsuo M, Kamoshida S, Hasegawa N, Asano S, Ito M.

Biochem Biophys Res Commun. 2019 Oct 30. pii: S0006-291X(19)32086-8. doi: 10.1016/j.bbrc.2019.10.176. [Epub ahead of print]

PMID:
31677798
3.

Insufficient serum L-ficolin is associated with disease presence and extent of pulmonary Mycobacterium avium complex disease.

Kobayashi T, Kuronuma K, Saito A, Ikeda K, Ariki S, Saitou A, Otsuka M, Chiba H, Takahashi S, Takahashi M, Takahashi H.

Respir Res. 2019 Oct 21;20(1):224. doi: 10.1186/s12931-019-1185-9.

4.

Adverse clinical events in Japanese atrial fibrillation patients with and without coronary artery disease-findings from the SAKURA AF Registry.

Fukamachi D, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Nichida T, Kojima T, Hanada S, Nomoto K, Sonoda K, Arima K, Kogawa R, Takahashi F, Kotani T, Ohkubo K, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; SAKURA AF Registry Investigators.

Curr Med Res Opin. 2019 Jul 29:1. doi: 10.1080/03007995.2019.1650014. [Epub ahead of print]

PMID:
31355684
5.

Usefulness of Dual-Phase Snapshot 320-Detector Computed Tomography for the Detection of a Left Atrial Appendage Thrombus.

Kuronuma K, Matsumoto N, Suzuki Y, Makita A, Ashida T, Yokoyama K, Yoda S, Okumura Y.

Int Heart J. 2019 Jul 27;60(4):849-853. doi: 10.1536/ihj.18-521. Epub 2019 Jul 12.

6.

University hospitals, general hospitals, private clinics: Place-based differences in patient characteristics and outcomes of AF-A SAKURA AF Registry Substudy.

Kogawa R, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Nishida T, Matsumoto M, Kojima T, Hanada S, Nomoto K, Sonoda K, Arima K, Takahashi F, Kotani T, Ohkubo K, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; SAKURA AF Registry Investigators.

J Cardiol. 2019 Jun 25. pii: S0914-5087(19)30151-0. doi: 10.1016/j.jjcc.2019.04.015. [Epub ahead of print]

PMID:
31253524
7.

Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation: a Japanese multicenter registry substudy.

Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, Matsumoto M, Kojima T, Haruta H, Nomoto K, Sonoda K, Arima K, Kogawa R, Takahashi F, Kotani T, Okubo K, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; , for the SAKURA AF Registry Investigators.

Curr Med Res Opin. 2019 Nov;35(11):2007-2013. doi: 10.1080/03007995.2019.1631597. Epub 2019 Jul 17.

PMID:
31204852
8.

Oral anticoagulant use and clinical outcomes in elderly Japanese patients: findings from the SAKURA AF Registry.

Nishida T, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Sonoda K, Arima K, Kogawa R, Takahashi F, Kotani T, Ohkubo K, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; SAKURA AF Registry Investigators.

Heart Vessels. 2019 Dec;34(12):2021-2030. doi: 10.1007/s00380-019-01446-6. Epub 2019 Jun 10.

PMID:
31183513
9.

Autoimmune Pulmonary Alveolar Proteinosis Diagnosed after Exposure to a Fire Extinguisher Containing Silica Powder.

Yorozuya T, Ikeda K, Chiba H, Saito A, Kuronuma K, Nishikiori H, Miyajima S, Takahashi M, Yoshikawa T, Takahashi Y, Taya T, Mori Y, Umeda Y, Otsuka M, Moriyama H, Takahashi H.

Intern Med. 2019 Jul 15;58(14):2067-2072. doi: 10.2169/internalmedicine.1557-18. Epub 2019 Apr 17.

10.

Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.

Shimbashi R, Chang B, Tanabe Y, Takeda H, Watanabe H, Kubota T, Kasahara K, Oshima K, Nishi J, Maruyama T, Kuronuma K, Fujita J, Ikuse T, Kinjo Y, Suzuki M, Kerdsin A, Shimada T, Fukusumi M, Tanaka-Taya K, Matsui T, Sunagawa T, Ohnishi M, Oishi K; and the Adult IPD Study Group.

PLoS One. 2019 Feb 21;14(2):e0212418. doi: 10.1371/journal.pone.0212418. eCollection 2019.

11.

Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry.

Murata N, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Arima K, Takahashi F, Kotani T, Ikeya Y, Fukushima S, Itoh S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; SAKURA AF Registry Investigators.

Circ J. 2019 Mar 25;83(4):727-735. doi: 10.1253/circj.CJ-18-0991. Epub 2019 Feb 5.

12.

Immunogenicity of pneumococcal vaccines in comorbid autoimmune and chronic respiratory diseases.

Kuronuma K, Takahashi H.

Hum Vaccin Immunother. 2019;15(4):859-862. doi: 10.1080/21645515.2018.1564443. Epub 2019 Jan 30.

PMID:
30698500
13.

Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: A SAKURA AF Registry substudy.

Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Arima K, Takahashi F, Kotani T, Ikeya Y, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; SAKURA AF Registry Investigators.

J Cardiol. 2019 Mar;73(3):210-217. doi: 10.1016/j.jjcc.2018.12.003. Epub 2018 Dec 24.

PMID:
30591323
14.

Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.

Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Kojima T, Arima K, Kotani T, Nomoto K, Ikeya Y, Fukushima S, Onikura M, Suzuki Y, Fujita M, Ando H, Ishikawa N, Hirayama A; SAKURA AF Registry Investigators.

Int Heart J. 2018 Nov 28;59(6):1266-1274. doi: 10.1536/ihj.17-649. Epub 2018 Oct 25.

15.

Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.

Shioya M, Otsuka M, Yamada G, Umeda Y, Ikeda K, Nishikiori H, Kuronuma K, Chiba H, Takahashi H.

Can Respir J. 2018 Aug 13;2018:6043053. doi: 10.1155/2018/6043053. eCollection 2018.

16.

Translin modulates mesenchymal cell proliferation and differentiation in mice.

Ikeuchi Y, Imanishi A, Sudo K, Fukunaga T, Yokoi A, Matsubara L, Goto C, Fukuoka T, Kuronuma K, Kono R, Hasegawa N, Asano S, Ito M.

Biochem Biophys Res Commun. 2018 Sep 26;504(1):115-122. doi: 10.1016/j.bbrc.2018.08.141. Epub 2018 Aug 29.

PMID:
30172368
18.

Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation - Findings From the SAKURA AF Registry.

Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Arima K, Takahashi F, Kotani T, Ikeya Y, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A; SAKURA AF Registry Investigators.

Circ J. 2018 Sep 25;82(10):2500-2509. doi: 10.1253/circj.CJ-18-0535. Epub 2018 Aug 4.

19.

Multiclonal Expansion and High Prevalence of β-Lactamase-Negative Haemophilus influenzae with High-Level Ampicillin Resistance in Japan and Susceptibility to Quinolones.

Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, Shiraishi T, Kuronuma K, Takahashi S, Takahashi H, Yokota SI.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00851-18. doi: 10.1128/AAC.00851-18. Print 2018 Sep.

20.

Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment.

Kuronuma K, Honda H, Mikami T, Saito A, Ikeda K, Otsuka M, Chiba H, Yamada G, Sato T, Yokota SI, Takahashi H.

Vaccine. 2018 Aug 9;36(33):4968-4972. doi: 10.1016/j.vaccine.2018.06.062. Epub 2018 Jul 6.

PMID:
29983256
21.

Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in mcr-Negative Escherichia coli Clinical Isolates, Including Major Multidrug-Resistant Lineages O25b:H4-ST131-H30Rx and Non-x.

Sato T, Shiraishi T, Hiyama Y, Honda H, Shinagawa M, Usui M, Kuronuma K, Masumori N, Takahashi S, Tamura Y, Yokota SI.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00864-18. doi: 10.1128/AAC.00864-18. Print 2018 Sep.

22.

Whole genome analysis of a multidrug-resistant Streptococcus pneumoniae isolate from a patient with invasive pneumococcal infection developing disseminated intravascular coagulation.

Ohkoshi Y, Sato T, Wada T, Fukushima Y, Murabayashi H, Takakuwa Y, Nishiyama K, Honda H, Shiraishi T, Kuronuma K, Takahashi H, Nakajima C, Suzuki Y, Yokota SI.

J Infect Chemother. 2018 Aug;24(8):674-681. doi: 10.1016/j.jiac.2018.01.012. Epub 2018 Feb 26.

PMID:
29496334
23.

Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.

Takahashi Y, Saito A, Chiba H, Kuronuma K, Ikeda K, Kobayashi T, Ariki S, Takahashi M, Sasaki Y, Takahashi H.

Respir Res. 2018 Feb 27;19(1):34. doi: 10.1186/s12931-018-0736-9.

24.

Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes.

Otsuka M, Shiratori M, Chiba H, Kuronuma K, Sato Y, Niitsu Y, Takahashi H.

Exp Lung Res. 2017 Aug - Sep;43(6-7):271-282. doi: 10.1080/01902148.2017.1354946. Epub 2017 Oct 16.

PMID:
29035148
25.

Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.

Hasegawa Y, Takahashi M, Ariki S, Saito A, Uehara Y, Takamiya R, Kuronuma K, Chiba H, Sakuma Y, Takahashi H, Kuroki Y.

J Biol Chem. 2017 Nov 10;292(45):18565-18576. doi: 10.1074/jbc.M117.800771. Epub 2017 Sep 27.

26.

Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone.

Ikeda K, Shiratori M, Chiba H, Nishikiori H, Yokoo K, Saito A, Hasegawa Y, Kuronuma K, Otsuka M, Yamada G, Takahashi H.

Respir Med. 2017 Oct;131:184-191. doi: 10.1016/j.rmed.2017.08.021. Epub 2017 Aug 24.

PMID:
28947028
27.

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry.

Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Arima K, Takahashi F, Kotani T, Ikeya Y, Fukushima S, Itoh S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A, The Sakura Af Registry Investigators.

J Arrhythm. 2017 Aug;33(4):289-296. doi: 10.1016/j.joa.2016.11.003. Epub 2017 Jan 2.

28.

Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients.

Umeda Y, Hasegawa Y, Otsuka M, Ariki S, Takamiya R, Saito A, Uehara Y, Saijo H, Kuronuma K, Chiba H, Ohnishi H, Sakuma Y, Takahashi H, Kuroki Y, Takahashi M.

Oncogene. 2017 Nov 16;36(46):6432-6445. doi: 10.1038/onc.2017.253. Epub 2017 Jul 24.

PMID:
28745320
29.

Congenital Pulmonary Vein Atresia in an Adult.

Kuronuma K, Kobayashi T, Takahashi Y, Takahashi H.

Intern Med. 2017;56(7):877-878. doi: 10.2169/internalmedicine.56.7590. Epub 2017 Apr 1. No abstract available.

30.

Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.

Yamada YI, Yamada G, Otsuka M, Nishikiori H, Ikeda K, Umeda Y, Ohnishi H, Kuronuma K, Chiba H, Baumbach JI, Takahashi H.

Lung. 2017 Apr;195(2):247-254. doi: 10.1007/s00408-017-9979-3. Epub 2017 Mar 1.

PMID:
28247041
31.

Surfactant protein A (SP-A) and SP-A-derived peptide attenuate chemotaxis of mast cells induced by human β-defensin 3.

Uehara Y, Takahashi M, Murata M, Saito A, Takamiya R, Hasegawa Y, Kuronuma K, Chiba H, Hashimoto J, Sawada N, Takahashi H, Kuroki Y, Ariki S.

Biochem Biophys Res Commun. 2017 Mar 25;485(1):107-112. doi: 10.1016/j.bbrc.2017.02.028. Epub 2017 Feb 8.

PMID:
28188794
32.

Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution.

Fukusumi M, Chang B, Tanabe Y, Oshima K, Maruyama T, Watanabe H, Kuronuma K, Kasahara K, Takeda H, Nishi J, Fujita J, Kubota T, Sunagawa T, Matsui T, Oishi K; Adult IPD Study Group.

BMC Infect Dis. 2017 Jan 3;17(1):2. doi: 10.1186/s12879-016-2113-y.

33.

Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis.

Kondoh S, Chiba H, Nishikiori H, Umeda Y, Kuronuma K, Otsuka M, Yamada G, Ohnishi H, Mori M, Kondoh Y, Taniguchi H, Homma S, Takahashi H.

Respir Investig. 2016 Sep;54(5):327-33. doi: 10.1016/j.resinv.2016.02.009. Epub 2016 Mar 30.

PMID:
27566380
34.

Surfactant protein D is a useful biomarker for monitoring acute lung injury in rats.

Murata M, Otsuka M, Ashida N, Yamada G, Kuronuma K, Chiba H, Takahashi H.

Exp Lung Res. 2016 Aug;42(6):314-21. doi: 10.1080/01902148.2016.1215570.

PMID:
27541374
35.

[THE CURRENT SITUATION OF FOREIGN TUBERCULOSIS PATIENTS AND THEIR CONCURRENT HIV INFECTION IN HOKKAIDO].

Ikeda K, Nishikiori H, Kondo S, Kobayashi T, Taya T, Mori Y, Shioya M, Kuronuma K, Takahashi H.

Kekkaku. 2016 Feb;91(2):33-9. Japanese.

PMID:
27263222
36.

Clinical Feasibility of Simultaneous Acquisition Rest (99m)Tc/Stress (201)Tl Dual-Isotope Myocardial Perfusion Single-Photon Emission Computed Tomography With Semiconductor Camera.

Makita A, Matsumoto N, Suzuki Y, Hori Y, Kuronuma K, Yoda S, Kasama S, Iguchi N, Suzuki Y, Hirayama A.

Circ J. 2016;80(3):689-95. doi: 10.1253/circj.CJ-15-1077. Epub 2016 Jan 18.

37.

Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis.

Nishikiori H, Chiba H, Ariki S, Kuronuma K, Otsuka M, Shiratori M, Ikeda K, Watanabe A, Kuroki Y, Takahashi H.

BMC Pulm Med. 2014 Dec 8;14:196. doi: 10.1186/1471-2466-14-196.

38.

Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.

Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, Bando M, Sugiyama Y, Takahashi H.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):773-9. doi: 10.1164/rccm.201403-0566OC.

PMID:
25162152
39.

Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.

Hayashi N, Chiba H, Kuronuma K, Go S, Hasegawa Y, Takahashi M, Gasa S, Watanabe A, Hasegawa T, Kuroki Y, Inokuchi J, Takahashi H.

Cancer Sci. 2013 Jan;104(1):43-7. doi: 10.1111/cas.12027. Epub 2012 Oct 30.

40.

Pulmonary surfactant protein A protects lung epithelium from cytotoxicity of human β-defensin 3.

Saito A, Ariki S, Sohma H, Nishitani C, Inoue K, Ebata N, Takahashi M, Hasegawa Y, Kuronuma K, Takahashi H, Kuroki Y.

J Biol Chem. 2012 Apr 27;287(18):15034-43. doi: 10.1074/jbc.M111.308056. Epub 2012 Mar 14.

41.

A case of adult T cell leukemia/lymphoma presenting as severe tracheal stenosis.

Otsuka K, Kuronuma K, Otsuka M, Kitada J, Narita Y, Homma H, Miyajima S, Kitamura Y, Suzuki Y, Natsuizaka M, Yasui H, Ikeda H, Hayashi T, Ishida T, Shinomura Y, Noguchi H, Takahashi H.

Intern Med. 2011;50(21):2637-41. Epub 2011 Nov 1.

42.

Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.

Kuronuma K, Mitsuzawa H, Takeda K, Nishitani C, Chan ED, Kuroki Y, Nakamura M, Voelker DR.

J Biol Chem. 2009 Sep 18;284(38):25488-500. doi: 10.1074/jbc.M109.040832. Epub 2009 Jul 7.

43.

Chronic expanding hematoma in the chest.

Kuronuma K, Ootake S, Ikeda K, Taniguchi M, Takezawa C, Takahashi H.

Intern Med. 2008;47(15):1411-4. Epub 2008 Aug 1.

44.

Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.

Chmura K, Bai X, Nakamura M, Kandasamy P, McGibney M, Kuronuma K, Mitsuzawa H, Voelker DR, Chan ED.

Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L220-30. doi: 10.1152/ajplung.90204.2008. Epub 2008 May 16.

45.

Regulation of inflammation and bacterial clearance by lung collectins.

Sano H, Kuronuma K, Kudo K, Mitsuzawa H, Sato M, Murakami S, Kuroki Y.

Respirology. 2006 Jan;11 Suppl:S46-50.

PMID:
16423271
46.

Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity.

Chiba H, Piboonpocanun S, Mitsuzawa H, Kuronuma K, Murphy RC, Voelker DR.

Respirology. 2006 Jan;11 Suppl:S2-6.

PMID:
16423264
47.

Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.

Hyakushima N, Mitsuzawa H, Nishitani C, Sano H, Kuronuma K, Konishi M, Himi T, Miyake K, Kuroki Y.

J Immunol. 2004 Dec 1;173(11):6949-54.

48.

Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor.

Kudo K, Sano H, Takahashi H, Kuronuma K, Yokota S, Fujii N, Shimada K, Yano I, Kumazawa Y, Voelker DR, Abe S, Kuroki Y.

J Immunol. 2004 Jun 15;172(12):7592-602.

49.

Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A.

Kuronuma K, Sano H, Kato K, Kudo K, Hyakushima N, Yokota S, Takahashi H, Fujii N, Suzuki H, Kodama T, Abe S, Kuroki Y.

J Biol Chem. 2004 May 14;279(20):21421-30. Epub 2004 Mar 1.

50.

[Small cell lung cancer associated with anti-Hu antibody-positive paraneoplastic neurologic syndrome].

Kuronuma K, Nishiyama K, Murakami S, Tanaka N, Takahashi M, Kojima H, Fujishima T, Tanaka H, Takahashi H, Koba H, Tanaka K, Abe S.

Nihon Kokyuki Gakkai Zasshi. 2000 Feb;38(2):148-52. Japanese.

PMID:
10774176

Supplemental Content

Loading ...
Support Center